Time Course of Cellular Proliferation, Intimal Hyperplasia, and Remodeling Following Angioplasty in Monkeys With Established Atherosclerosis
- 1 January 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 16 (1) , 34-43
- https://doi.org/10.1161/01.atv.16.1.34
Abstract
Abstract Animal models of arterial injury have failed to predict effective therapy to prevent restenosis in humans. While this may relate to species differences in the control of smooth muscle cell growth, many studies have used nonatherosclerotic animals, thereby failing to consider the importance of atherosclerosis in the response to injury. In an attempt to model human restenosis more accurately, we characterized the response to angioplasty in atherosclerotic monkeys. Twenty-one cynomolgus monkeys were fed an atherogenic diet for 36 months (plasma cholesterol, 12±1 mmol/L [470±23 mg/dL]). Angioplasty was then performed in the left iliac artery. After 4, 7, 14, or 28 days, bromodeoxyuridine was given to label proliferating cells, and iliac arteries were fixed in situ at physiological pressure (5 or 6 animals at each time point). Comparisons were made between injured and uninjured iliac arteries within each animal. Angioplasty often fractured the intimal plaque and media, transiently increasing lumen caliber (4 days: lumen area, 232.5±80.3% of control) and artery size as reflected by external elastic lamina area (EEL). EEL and lumen caliber returned to baseline by 7 days. Proliferation was increased throughout the artery wall at 4 and 7 days and later declined to control rates (4 days, injured versus uninjured: adventitia, 45.0±6.2% versus 16.3±7.2%; media, 8.6±2.6% versus 0.6±0.1%; intima, 16.0±5.6% versus 7.8±3.1%). The intima thickened markedly from 14 to 28 days, but an increase in EEL generally prevented further loss of the short-term gain in lumen caliber (28 days, percent of control: intimal area, 342.8±88.9%; EEL area, 150.2±28.9%; lumen area, 119.3±21.3%). The response to angioplasty in atherosclerotic monkeys appears to closely resemble that in humans. Plaque fracture, delayed recoil, intimal hyperplasia, and remodeling may each be important in determining late lumen caliber. This primate model should prove valuable in defining cellular and biochemical mediators of human restenosis.Keywords
This publication has 16 references indexed in Scilit:
- Long-term angiographic follow-up of lesions patent 6 months after percutaneous coronary angioplastyAmerican Heart Journal, 1995
- Clinical and lesion morphologic determinants of coronary angioplasty success and complications: Current experienceJournal of the American College of Cardiology, 1995
- Predictors of restenosis: A morphometric and quantitative evaluation by intravascular ultrasoundAmerican Heart Journal, 1994
- Animal models of restenosisTrends in Cardiovascular Medicine, 1994
- Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization.Journal of Clinical Investigation, 1993
- Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.Hypertension, 1991
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1987
- Suppression by heparin of smooth muscle cell proliferation in injured arteriesNature, 1977